Which therapy for helicobacter pylori infection?

Gastroenterology

Volumn 143, Issue 1, 2012, Pages 10-12

  Graham, David Y ^a   Shiotani, Akiko ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; DRUG MEGADOSE; DRUG TOLERABILITY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84862739169     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.05.012     Document Type: Editorial

References (16)

1. A. Federico, G. Nardone, A.G. Gravina Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection Gastroenterology 143 2012 55 61
2. D.Y. Graham, M.P. Dore Helicobacter pylori therapy demystified Helicobacter 16 2011 343 345
3. Y. Li, X. Huang, L. Yao Advantages of moxifloxacin and levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis Wien Klin Wochenschr 122 2010 413 422
4. L. Gatta, N. Vakil, G. Leandro Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children Am J Gastroenterol 104 2009 3069 3079
5. D.Y. Graham Helicobacter pylori eradication therapy research: ethical issues and description of results Clin Gastroenterol Hepatol 8 2010 1032 1036
6. R.E. Pounder, N.J. Talley Letter: the ethics of using inferior regimens in H pylori randomised trials: editors' reply Aliment Pharmacol Ther 35 2012 858
7. T. Lind, F. Megraud, P. Unge The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies Gastroenterology 116 1999 248 253
8. T.A. Attumi, D.Y. Graham Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study J Gastroenterol Hepatol 27 2012 59 61
9. P. Moayyedi, P. Malfertheiner Editorial: sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? Am J Gastroenterol 104 2009 3081 3083
10. R.J. Saad, P. Schoenfeld, H.M. Kim Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis Am J Gastroenterol 101 2006 488 496
11. S. Miehlke, S. Krasz, W. Schneider-Brachert Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection Helicobacter 16 2011 420 426
12. M.S. Osato, R. Reddy, S.G. Reddy Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori Int J Antimicrob Agents 17 2001 39 44
13. D.Y. Graham Efficient identification and evaluation of effective Helicobacter pylori therapies Clin Gastroenterol Hepatol 7 2009 145 148
14. D.Y. Graham, E. Rimbara Understanding and appreciating sequential therapy for Helicobacter pylori eradication J Clin Gastroenterol 45 2011 309 313
15. D.Y. Graham, L. Fischbach Helicobacter pylori treatment in the era of increasing antibiotic resistance Gut 59 2010 1143 1153
16. P.I. Hsu, D.C. Wu, J.Y. Wu Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days Helicobacter 16 2011 139 145